Cheryl Guttman Krader
Automated capsulotomy device provides safe, consistent results
A disposable device for automated anterior capsulotomy that uses precision pulse technology (Zepto, Mynosys Cellular Devices) demonstrated excellent performance in a series of 38 eyes.
Combined cataract/EK surgery may require modifications to technique
Cataract surgery in eyes undergoing simultaneous endothelial keratoplasty requires several modifications in techniques.
5 observations about corticosteroids for DME treatment
Findings from studies investigating intravitreal corticosteroids for treatment of diabetic macular edema (DME) provide information about their efficacy and safety, including some understanding of how they compare with anti-VEGF therapy.
How wide-field SS-OCT expands spectrum of normal peripheral retina
Wide-field retinal imaging can be performed using a commercially available swept-source optical coherence tomography (SS-OCT) platform (DRI OCT Triton, Topcon) and only the internal fixation light for patient navigation provided detailed images of both normal and pathologic peripheral retinal findings.
Sirolimus shows promise for posterior segment non-infectious uveitis
Intravitreal sirolimus 400 mcg (Ospiria, Santen) demonstrated positive results in pivotal trials investigating it as a treatment for non-infectious uveitis of the posterior segment. A New Drug Application is under FDA review.
Systemic safety of anti-VEGF treatment for ROP mandates further study
Systemic safety of anti-VEGF treatment for ROP mandates further study
Accumulating evidence is cause for concern and underscoring the need for more research evaluating the safety of anti-VEGF injections for ROP, according to Robert L. Avery, MD.
Prostate Ca immunotherapy induces T-cell response
A study aimed at further elucidating the mechanism of action of sipuleucel-T (Provenge) in advanced prostate cancer provides fairly convincing evidence that the immunotherapy agent induces T-cell responses in humans, says Charles G. Drake, MD, PhD.
Factors in prostate Ca decision-making vary by race
Patients newly diagnosed with prostate cancer show race-related differences in what men perceive as important factors in their treatment decision-making process.
BMI predicts post-RP metastasis, PCa mortality
Findings from a recent study also suggest that obesity may be a factor to consider for men with prostate cancer deciding between active surveillance and definitive treatment.
Pre-RP MRI does not affect surgical outcomes
Results of a retrospective case-cohort study show no significant differences in surgical outcomes among men who did and did not have preoperative magnetic resonance imaging of the prostate prior to radical prostatectomy for prostate cancer.

Poll